What is cardiac rehabilitation and does it actually work?

Cardiac rehabilitation is a structured programme, usually lasting six to twelve weeks, combining supervised exercise training with education, risk factor management, medication optimisation and psychological support after a heart attack, cardiac surgery, stenting, or a diagnosis of heart failure. It works: systematic reviews show it reduces cardiovascular deaths and hospital admissions and improves quality of life, with benefits comparable in size to several drugs that are prescribed routinely and without question. It carries the highest level of recommendation in every major international guideline. The difference is that the drugs are almost always prescribed, whereas rehabilitation is frequently not referred, not offered in a form that fits people's lives, and not completed.

Why do so few people who need it actually attend?

The biggest single reason is that they are never referred — referral failure loses more eligible patients than every other barrier combined, which is why automatic opt-out referral before discharge is such an effective fix. Beyond that, the obstacles are largely practical rather than medical: programmes run during working hours, which excludes anyone employed; they require travel to a hospital, which excludes those without transport or money for it; they assume a person can attend twice a week for eight weeks, which excludes carers; and they are frequently designed around a model of a middle-aged man after a heart attack, which fits many patients poorly. Attendance is consistently lowest among women, older people, ethnic minority groups and people in deprived areas — the groups at highest risk.

Can rehabilitation be done at home?

Yes, and for most patients it is just as effective. Randomised trials and Cochrane reviews comparing home-based with hospital-based programmes have found equivalent outcomes in low and moderate-risk patients, and in several studies better adherence at home, since the practical obstacles are removed. Home programmes are supported by telephone contact, video consultation, smartphone applications, wearable activity monitors and written exercise plans, with an initial assessment and periodic review. Higher-risk patients — those with significant heart muscle weakness, exercise-induced chest pain or rhythm disturbances, or recent decompensation — are better served by supervised sessions at least initially. The most sensible model offers a genuine menu, so patients can choose the format that fits their circumstances rather than declining altogether.

Is exercise safe after a heart attack or with heart failure?

Yes, when prescribed appropriately — and avoiding exercise is the more dangerous option. Serious cardiac events during supervised rehabilitation exercise are rare, and the risks of remaining sedentary are substantial and certain. For heart failure specifically, patients were once advised to rest; that advice has been reversed by trial evidence showing that exercise training improves capacity and quality of life and reduces hospital admissions. Much of the benefit comes from improvements in the muscles, blood vessels and autonomic nervous system rather than from changes to the heart's pumping fraction, which is why people often feel considerably better without the echocardiogram changing. Exercise begins at a level matched to current capacity and progresses gradually, and this is precisely what a rehabilitation programme is designed to supervise safely.

Why does mental health matter after a cardiac event?

Because it affects both wellbeing and physical outcome. Around one in five people develop depression after a heart attack, and depression independently predicts further cardiac events and death, not merely reduced quality of life. Anxiety is even commoner, and takes a particular form: fear that exertion will cause another event, leading to progressive avoidance of activity, deconditioning, more breathlessness on exertion, and reinforcement of the fear. This cycle is very difficult to break through information alone, which is one of the strongest arguments for supervised exercise — being shown, in a monitored setting, that the heart tolerates exertion safely is a powerful and specific treatment for that fear. Screening for depression and anxiety, and offering psychological support, is a core part of rehabilitation and one of the most frequently omitted.

How does GMJ News cover cardiac rehabilitation?

GMJ News covers the mortality and hospitalisation evidence from Cochrane reviews, the Class I guideline status against real-world under-delivery, the participation cascade and referral failure, the systematic inequity in uptake by sex, age, ethnicity and deprivation, home-based and digital delivery equivalence, core components beyond exercise including medication titration and vocational support, exercise prescription and risk stratification, cardiopulmonary exercise testing, rehabilitation in heart failure including HF-ACTION and REHAB-HF, depression and fear-avoidance after cardiac events, return to work and driving regulation, and low-resource delivery models. Directly relevant to PHIG's rehabilitation, NCD and health equity programmes.

Home › Topics › Cardiac Rehabilitation

Cardiac Rehabilitation

GMJ News knowledge hub · last reviewed September 2026 · Georgian Medical Journal

Summary Statistics Glossary GMJ news FAQ Documents Organizations Research

Exercise-based cardiac rehabilitation is one of the most robustly evidenced interventions in cardiovascular medicine, with Cochrane reviews demonstrating reduced cardiovascular mortality, fewer hospital admissions and improved quality of life after myocardial infarction, revascularisation and in heart failure — benefits comparable in magnitude to several widely prescribed drugs, delivered without pharmacological adverse effects (WHO). Despite this evidence and its inclusion as a Class I recommendation in every major guideline, cardiac rehabilitation remains among the most under-delivered treatments in medicine: uptake typically reaches only a minority of eligible patients even in well-resourced systems, and is markedly lower among women, older people, ethnic minorities, those in deprived areas and people with heart failure — a gap driven by failure to refer, transport and work barriers, and programme designs built around supervised hospital attendance, which the demonstrated equivalence of home-based and technology-supported delivery now makes unnecessary.

Key messages

Mortality benefit comparable to drugs — with no pharmacological toxicity

Cochrane reviews of exercise-based cardiac rehabilitation after myocardial infarction and revascularisation show reduced cardiovascular mortality, fewer hospital admissions and improved health-related quality of life; in heart failure with reduced ejection fraction, rehabilitation reduces hospitalisation and improves quality of life. The magnitude is comparable to several routinely prescribed medications. It carries a Class I recommendation in ESC, AHA/ACC and every other major guideline, yet is prescribed and delivered far less reliably than drugs with equivalent evidence.

Among the most under-delivered treatments in medicine

Uptake typically reaches only a minority of eligible patients even in well-resourced health systems, with participation commonly reported at 20-50% of those referred and completion lower still. The gap is not explained by patient unsuitability. The main drivers are failure to refer at all — the single largest determinant — followed by transport and cost, work and caring commitments, programme timing during working hours, and distance. Automatic referral with opt-out, rather than clinician-initiated opt-in, substantially increases enrolment and is one of the simplest system-level fixes available.

The inequity is systematic and predictable

Participation is consistently lower among women, older people, ethnic minority groups, people living in deprived areas, those with lower educational attainment, non-native language speakers, and patients with heart failure rather than after myocardial infarction — precisely the groups with the greatest baseline risk and the most to gain. This is a textbook illustration of the inverse care law operating within a service that is free at the point of use in many systems, demonstrating that removing financial barriers alone does not produce equitable access when programme design assumes daytime availability, private transport and cultural familiarity.

Home-based and digital delivery are equivalent — removing the main structural barrier

Randomised comparisons and Cochrane synthesis show that home-based cardiac rehabilitation produces outcomes equivalent to centre-based programmes for low and moderate-risk patients, with better adherence in several studies. Telehealth, smartphone-supported programmes and wearable-monitored exercise expand this further. Since the dominant barriers are logistical rather than clinical, this evidence largely dissolves the justification for a hospital-attendance-only model. The optimal configuration is menu-based: patients choose centre-based, home-based, digital or hybrid delivery according to their circumstances, with higher-risk patients supervised initially.

Rehabilitation is comprehensive secondary prevention, not just exercise

The exercise component is necessary but insufficient. Core components: structured exercise training, individually prescribed and progressed; smoking cessation support; dietary counselling and weight management; lipid, blood pressure and glycaemic optimisation with medication titration, which programmes are well placed to deliver systematically; psychological assessment and support; education and self-management skills; and vocational support for return to work and driving advice. Programmes that deliver only supervised exercise classes miss much of the available benefit, particularly the medication optimisation and psychological components.

Depression and anxiety after cardiac events are common, prognostic and undertreated

Depression affects roughly one in five patients after myocardial infarction and independently predicts mortality and recurrent events, while anxiety and cardiac-specific fear of exertion drive avoidance behaviour that directly undermines recovery. Screening within rehabilitation programmes is straightforward and effective, and psychological intervention improves both mood and adherence. Two practical points: exercise itself has antidepressant effect and is part of the treatment; and explicit, structured reassurance about the safety of exertion — including supervised demonstration that symptoms do not occur — addresses the fear-avoidance cycle that many patients cannot resolve through information alone.

Key statistics

Class I

recommendation for cardiac rehabilitation in ESC, AHA/ACC and all major guidelines

ESC/AHA

Reduced mortality

exercise-based rehabilitation reduces cardiovascular mortality and hospital admissions after MI

Cochrane

20-50%

typical participation among eligible patients even in well-resourced systems

EuroAspire/BACPR

Referral failure

the single largest determinant of non-participation — automatic opt-out referral substantially increases uptake

AHA/BACPR

Home-based

equivalent outcomes to centre-based rehabilitation for low and moderate-risk patients

Cochrane

~1 in 5

patients have depression after myocardial infarction — independently predicting mortality

AHA/EACPR

Cardiac rehabilitation — the participation cascade from eligibility to completion

Source: Registry and audit data. Attrition occurs at every step, with referral failure the largest single loss.

Glossary of key terms

Core components and phases
RehabilitationPhase I: inpatient — early mobilisation, reassurance, initial education, and referral arrangement before discharge, which is when referral is most reliably achieved. Phase II: outpatient structured programme, typically 6-12 weeks, comprising supervised or supported exercise training, risk factor modification, psychological support and education. Phase III: long-term maintenance, where the transition from supervised programme to sustained independent activity is the point at which most gains are lost. The BACPR and EACPR core component frameworks specify: lifestyle risk factor management including physical activity, diet and smoking; psychosocial health; medical risk factor management; cardioprotective therapies with medication titration; long-term management; and audit and evaluation. Programmes delivering exercise alone meet only one of these.

Exercise prescription and risk stratification
Exercise physiologyPrescription follows the FITT framework — frequency, intensity, time and type — individualised to baseline capacity, usually assessed by exercise testing, six-minute walk test or incremental shuttle walk. Aerobic training is typically prescribed at 40-80% of heart rate reserve or a rating of perceived exertion of 11-14 on the Borg scale, three to five times weekly, progressing in duration before intensity. Resistance training is now firmly included rather than avoided, improving strength, function and metabolic outcomes without adverse cardiac effects when appropriately prescribed. High-intensity interval training achieves greater improvement in peak oxygen uptake than moderate continuous training in selected patients. Risk stratification determines supervision level: patients with significant ventricular dysfunction, exercise-induced ischaemia or arrhythmia, or recent decompensation require supervised programmes with monitoring.

Cardiopulmonary exercise testing
AssessmentCPET measures ventilatory gas exchange during incremental exercise, providing objective, effort-independent measures that guide both prognosis and prescription. Key variables: peak oxygen uptake (VO2 peak), a powerful prognostic marker in heart failure and a criterion in transplant assessment; the ventilatory anaerobic threshold, which defines a physiologically rational training intensity; and the VE/VCO2 slope, a measure of ventilatory efficiency that carries independent prognostic weight. CPET also distinguishes cardiac from pulmonary, muscular and deconditioning causes of exertional limitation — a common clinical question in patients with multiple comorbidities where breathlessness has been assumed to be cardiac. It is additionally used in preoperative risk assessment before major surgery.

Return to work and driving
Occupational healthVocational rehabilitation is a core component that is routinely neglected, despite work being central to identity, income and mental health after a cardiac event. Structured occupational assessment and phased return substantially improve return-to-work rates, and prolonged unnecessary absence is itself associated with worse outcomes and reduced likelihood of ever returning. Driving restrictions vary by jurisdiction and by licence class, are considerably longer for vocational licences, and depend on the event, treatment and ventricular function — patients frequently receive inconsistent or incorrect advice, and programmes should provide clear written guidance referenced to national regulations. Airline pilots, commercial drivers, divers and others in safety-critical occupations require specific regulatory assessment.

Rehabilitation in heart failure
CardiologyHistorically patients with heart failure were advised to rest; the evidence now clearly supports exercise training. HF-ACTION demonstrated safety with modest improvement in outcomes, and subsequent trials and meta-analyses show improved exercise capacity, quality of life and reduced hospitalisation. Benefit is mediated substantially through peripheral adaptations — skeletal muscle oxidative capacity, endothelial function and autonomic balance — rather than through changes in ejection fraction, which explains why symptomatic improvement can be marked without measurable change on echocardiography. The REHAB-HF trial extended this to older adults hospitalised with acute decompensated heart failure, showing that a tailored programme addressing strength, balance, mobility and endurance improved physical function in a frail population previously excluded from rehabilitation.

Rehabilitation in low-resource settings
Global healthCardiac rehabilitation is available in only a minority of countries worldwide, and where it exists in low- and middle-income settings it typically reaches a small fraction of eligible patients. Since the burden of cardiovascular disease is now concentrated in these countries, this is a substantial and growing gap. Low-cost models with demonstrated feasibility include: community and home-based programmes delivered by trained non-specialist health workers; group walking and simple resistance programmes requiring no equipment; integration into existing primary care and NCD clinic structures rather than creating standalone services; and mobile phone-based support, which is feasible given high mobile penetration in most settings. The International Council of Cardiovascular Prevention and Rehabilitation has developed specific low-resource implementation guidance.